Sales rise 5.83% to Rs 120.80 crore
Net profit of Astrazeneca Pharma India reported to Rs 38.13 crore in the quarter ended March 2015 as against net loss of Rs 2.57 crore during the previous quarter ended March 2014. Sales rose 5.83% to Rs 120.80 crore in the quarter ended March 2015 as against Rs 114.15 crore during the previous quarter ended March 2014.For the full year,net loss reported to Rs 20.84 crore in the year ended March 2015 as against net loss of Rs 0.51 crore during the previous year ended March 2014. Sales declined 0.99% to Rs 469.05 crore in the year ended March 2015 as against Rs 473.75 crore during the previous year ended March 2014.
ParticularsQuarter EndedYear EndedMar. 2015Mar. 2014% Var.Mar. 2015Mar. 2014% Var.Sales120.80114.15 6 469.05473.75 -1 OPM %33.77-13.06 --2.43-2.74 - PBDT42.15-13.49 LP -5.56-3.77 -47 PBT38.13-16.46 LP -20.84-13.89 -50 NP38.13-2.57 LP -20.84-0.51 -3986
Powered by Capital Market - Live News
